Pacemakers Do Not Interfere with CGM Systems
A pacemaker will not interfere with the function or accuracy of a continuous glucose monitor (CGM). Mobile phones and other common electronic devices do not affect CGM devices 1, and recent research specifically demonstrates that implantable cardioverter defibrillator (ICD) devices—which are more complex than pacemakers—do not impact CGM accuracy or functionality 2.
Evidence Supporting Safe Coexistence
The most definitive evidence comes from a 2024 study that directly tested whether implantable cardiac devices interfere with CGM systems 2. This research evaluated FreeStyle Libre CGM systems in the presence of ICD devices using five different testing methodologies, including:
- High-energy emergency shocking
- Various pacing modes
- Anti-tachycardia pacing (ATP)
- DC Fibber mode
All acceptance criteria were met, demonstrating that coexisting ICD devices and CGM systems provide safe and effective wireless communications with functional and accurate data transfer during all expected clinical scenarios 2. Since ICDs deliver electrical shocks and have more complex electromagnetic functions than pacemakers, this evidence strongly supports that standard pacemakers pose no interference risk.
What Actually Interferes with CGM
Guidelines clearly specify the actual contraindications for CGM use 1:
Avoid CGM during:
- MRI (magnetic resonance imaging) examinations
- Conventional X-ray imaging
- CT (computed tomography) scanning
- Exposure to strong magnetic fields
Mobile phones and standard electronic devices do not affect CGM function 1.
Clinical Considerations for Cardiac Device Patients
For patients with both diabetes and cardiac devices:
- Sensor placement: Place CGM sensors on the abdomen or arm opposite to any arteriovenous fistulas/grafts if present 3
- No special precautions needed for the pacemaker itself
- Continue normal CGM use without interruption related to the cardiac device
Common Pitfalls to Avoid
Do not unnecessarily remove or discontinue CGM in patients with pacemakers. CGM disruption is already common due to device malfunction, insertion problems, and medical procedures 4. In one survey, 85.4% of CGM users experienced device malfunction, and adverse glycemic events (hyperglycemia or hypoglycemia) occurred ≥4 times in 36.5% of users due to CGM disruption 4. Adding unnecessary removal for pacemaker concerns would only worsen glycemic control without medical justification.
The only cardiac-related scenario requiring CGM removal would be if the patient needs an MRI or other imaging study that is contraindicated with CGM—not because of the pacemaker itself, but because of the imaging modality 1.